Bioscience

Verdosome introduces the COVID Pod for virus testing

Verdosome introduces the COVID Pod for virus testing

WHEAT RIDGE -- Verdosome announced the introduction of its COVID Pod ™ technology for the testing of SARS-CoV-2, the virus that causes COVID-19. COVID Podstands for " COllection Via... Read More

Thursday July 2, 2020 0 comments Tags: Wheat Ridge, Verdosome, COVID-19, COVID Pod, Beau Gertz

CSU: Using cellular networks to detect at-risk areas for spread of COVID

CSU: Using cellular networks to detect at-risk areas for spread of COVID

FORT COLLINS -- In the fight against COVID-19, researchers at Colorado State University have developed a new, non-invasive strategy to identify areas at greatest risk for spreading the... Read More

Thursday July 2, 2020 0 comments Tags: Fort Collins, CSU, COVID-19, Edwin Chong

Crestone secures NIH funding for development through phase 1 of novel antibiotic candidate

Crestone secures NIH funding for development through phase 1 of novel antibiotic candidate

BOULDER -- Crestone, Inc. today announced a contract award from the National Institutes of Health for the advancement of its antibiotic candidate CRS0540 to treat infections caused by... Read More

Wednesday July 1, 2020 0 comments Tags: Boulder, Crestone, Urs Ochsner, NIH

CSU secures award from U.S. government for development of SolaVAX vaccine manufacturing process for SARS-CoV-2

CSU secures award from U.S. government for development of SolaVAX vaccine manufacturing process for SARS-CoV-2

FORT COLLINS -- A team of infectious disease researchers at Colorado State University has entered into an agreement with the Biomedical Advanced Research and Development Authority ... Read More

Friday June 26, 2020 0 comments Tags: Fort Collins, CSU, Alan Rudolph, Ray Goodrich, BARDA

MBio Diagnostics and BARDA partner on 5-minute, quantitative POC COVID-19 antibody panel

MBio Diagnostics and BARDA partner on 5-minute, quantitative POC COVID-19 antibody panel

BOULDER -- MBio Diagnostics today announced it has been awarded a$629,595contract from the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant... Read More

Wednesday June 24, 2020 0 comments Tags: Boulder, MBio Diagnostics, BARDA, COVID-19, Chris Myatt

ArcherDX and Invitae combine to create global leader in comprehensive cancer genetics and precision oncology

ArcherDX and Invitae combine to create global leader in comprehensive cancer genetics and precision oncology

BOULDER and SAN FRANCISCO– ArcherDX ,a leading genomics analysis company democratizing precision oncology, and San Francisco-based Invitae (NYSE: NVTA), a leading genetics company, today... Read More

Monday June 22, 2020 0 comments Tags: Boulder, ArcherDx, Invitae, Jason Myers, Sean George

Ampio to begin first clinical trial in COVID-19 program

Ampio to begin first clinical trial in COVID-19 program

ENGLEWOOD -- Ampio Pharmaceuticals, Inc . (NYSE American: AMPE) announced it is developing therapies for patients infected with the SARS-CoV-2 virus ("COVID-19"). The U.S. Food and Drug... Read More

Monday June 22, 2020 0 comments Tags: Englewood, Ampio Pharmaceuticals, Ampion, COVID-19

ArcherDX collaborates with Bristol Myers Squibb to apply personalized cancer monitoring to clinical research

ArcherDX collaborates with Bristol Myers Squibb to apply personalized cancer monitoring to clinical research

BOULDER -- ArcherDX, Inc . announced it is entering into a collaboration with Bristol Myers Squibb (BMS) to utilize Personalized Cancer Monitoring (PCM) assays to understand the potential benefits... Read More

Friday June 19, 2020 0 comments Tags: Boulder, ArcherDx, Jason Myers